ALPS Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-175,285
| Closed | -$491K | – | 993 |
|
|
2024
Q3 | $491K | Buy |
175,285
+12,427
| +8% | +$34.8K | ﹤0.01% | 615 |
|
|
2024
Q2 | $379K | Buy |
162,858
+44,172
| +37% | +$103K | ﹤0.01% | 665 |
|
|
2024
Q1 | $531K | Buy |
118,686
+32
| +0% | +$143 | ﹤0.01% | 586 |
|
|
2023
Q4 | $381K | Sell |
118,654
-5,064
| -4% | -$16.3K | ﹤0.01% | 708 |
|
|
2023
Q3 | $392K | Buy |
123,718
+16,515
| +15% | +$52.4K | ﹤0.01% | 628 |
|
|
2023
Q2 | $533K | Buy |
+107,203
| New | +$533K | ﹤0.01% | 603 |
|
|
2022
Q4 | – | Sell |
-78,536
| Closed | -$848K | – | 1024 |
|
|
2022
Q3 | $848K | Sell |
78,536
-6,654
| -8% | -$71.8K | 0.01% | 499 |
|
|
2022
Q2 | $971K | Buy |
+85,190
| New | +$971K | 0.01% | 482 |
|